Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
0.968
-0.004 (-0.43%)
At close: May 31, 2024, 4:00 PM
0.990
+0.022 (2.27%)
After-hours: May 31, 2024, 7:51 PM EDT
Bionano Genomics Revenue
Bionano Genomics had revenue of $37.47M in the twelve months ending March 31, 2024, with 26.93% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $8.77M with 18.26% year-over-year growth. In the year 2023, Bionano Genomics had annual revenue of $36.12M with 29.90% growth.
Revenue (ttm)
$37.47M
Revenue Growth
+26.93%
P/S Ratio
1.73
Revenue / Employee
$108,924
Employees
344
Market Cap
64.72M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 36.12M | 8.31M | 29.90% |
Dec 31, 2022 | 27.80M | 9.82M | 54.62% |
Dec 31, 2021 | 17.98M | 9.48M | 111.47% |
Dec 31, 2020 | 8.50M | -1.63M | -16.06% |
Dec 31, 2019 | 10.13M | -1.87M | -15.59% |
Dec 31, 2018 | 12.00M | 2.50M | 26.26% |
Dec 31, 2017 | 9.51M | 2.71M | 39.93% |
Dec 31, 2016 | 6.79M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cryo-Cell International | 31.37M |
CollPlant Biotechnologies | 10.62M |
Affimed | 9.19M |
EUDA Health Holdings | 3.71M |
Dyadic International | 2.26M |
BNGO News
- 25 days ago - Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress - GlobeNewsWire
- 7 weeks ago - Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing - GlobeNewsWire
- 2 months ago - Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics - GlobeNewsWire
- 3 months ago - Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys™ System - GlobeNewsWire
- 3 months ago - Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 - GlobeNewsWire
- 3 months ago - Bionano to Present at TD Cowen's 44th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024 - GlobeNewsWire